Drotrecogin alfa
Drotrecogin alfa is activated human protein C that is synthesized by recombinant DNA technology. It is a glycoprotein of approximately 55 kilodalton molecular weight, consisting of a heavy chain and a light chain linked by a disulfide bond. Drotrecogin alfa was withdrawn from the market after a major study indicated that it was not effective in improving outcomes in patients with sepsis.
| Trivial name | PROC |
| Catalog Number | TP-052CL |
| Alternative Name(s) | Drotrecogin alfa |
| Research Area | Haemostasis and thrombosis |
| Molecular Formula | C1786H2779N509O519S29 |
| CAS# | 60202-16-6 |
| Purity | >90% |
| Size | 1 mg |
| Supplier Page | https://www.creativebiolabs.net/Drotrecogin-alfa-22390.htm |
| Additional Information | For reduction of mortality in patients with severe sepsis. |